Support research breakthroughs
You can help fund groundbreaking research where the results won't just be seen in the lab. They'll be seen in life changing breakthroughs for people with Parkinson's.
With your support, we can continue to explore every angle in our search for new and better treatments for Parkinson's.
Bringing new drugs and treatments into the hands of people with Parkinson's costs millions, and there is a critical funding gap which is stalling possible treatments before they've had the chance to be developed.
The Parkinson's Virtual Biotech, our global drug discovery and development programme, is bridging this gap, and we believe new treatments are within our reach.
Will you help fund pioneering new research through the Parkinson's Virtual Biotech?
£30 could go towards chemicals that can help researchers to visualise a troublesome form of alpha-synuclein in brain cells in Parkinson's.
- Paypal accepted
- Mastercard accepted
- Visa accepted
- American Express accepted
Find out more about the Parkinson's Virtual Biotech.
The Parkinson's Virtual Biotech is our global drug discovery and development programme, in partnership with the Parkinson's Foundation.
People with Parkinson's need new treatments now, but drug development takes years.
Through the Virtual Biotech, we're bridging the gap and investing in projects with the greatest potential to transform life for people with Parkinson's. We invest in rapidly testing and developing them, utilising labs and working with Biotechs and scientists across the world. We're accelerating the search for new treatments.
Watch the video below to learn more about how your donations are driving forward discoveries.
Your donation could support projects like these today
There are so many ways your donation will have a huge impact, and research like this is only possible with your support.
These are just 2 of the 12 projects in our Virtual Biotech portfolio right now. Read on to find out more about them
Unlocking brain inflammation
There is more inflammation in the brain cells affected by Parkinson's, Scientists believe this damages the dopamine-producing brain cells, progressing the condition. Neumora Therapeutics are developing a new drug that could help protect the precious brain cells by stopping inflammation being triggered in the brain. The aim is to slow or stop the progression of Parkinson's.
Protecting brain cells
Mitochondria have a key role in cells to produce energy - like tiny batteries. But in Parkinson's, the mitochondria stop working properly, damaging the cells they are in and stopping them from functioning. Repairing mitochondria could save dying brain cells and stop the progression. Lucy Therapeutics have developed molecules that early experiments show can target a key part of the mitochondria and improve their function.
Will you give a gift today?
Or choose a specific project to support
We know brain cell communication and recycling systems are affected in Parkinson's, but why and how do they interact? And what role do they play in the development of Parkinson's? That is what Dr Dayne Beccano-Kelly and his team at Cardiff University are investigating.
Toxic clumps of alpha-synuclein can form Lewy bodies in the gut. We know that these can lead to the movement symptoms associated with Parkinson's. Professor Spillantini and her team are aiming to find out how this happens and how they travel to the brain.
The Parkinson's UK Brain Bank was established in 1984 at Imperial College London. Scientists around the world access the Brain Bank to deepen their understanding of the condition whilst searching for better treatments and ultimately a cure.